These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 10737747

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. New selective and potent 5-HT(1B/1D) antagonists: chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides.
    Liao Y, Böttcher H, Harting J, Greiner H, van Amsterdam C, Cremers T, Sundell S, März J, Rautenberg W, Wikström H.
    J Med Chem; 2000 Feb 10; 43(3):517-25. PubMed ID: 10669578
    [Abstract] [Full Text] [Related]

  • 3. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
    Martínez-Esparza J, Oficialdegui AM, Pérez-Silanes S, Heras B, Orús L, Palop JA, Lasheras B, Roca J, Mourelle M, Bosch A, Del Castillo JC, Tordera R, Del Río J, Monge A.
    J Med Chem; 2001 Feb 01; 44(3):418-28. PubMed ID: 11462981
    [Abstract] [Full Text] [Related]

  • 4. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.
    Watson J, Roberts C, Scott C, Kendall I, Collin L, Day NC, Harries MH, Soffin E, Davies CH, Randall AD, Heightman T, Gaster L, Wyman P, Parker C, Price GW, Middlemiss DN.
    Br J Pharmacol; 2001 Jul 01; 133(6):797-806. PubMed ID: 11454652
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
    Orús L, Pérez-Silanes S, Oficialdegui AM, Martínez-Esparza J, Del Castillo JC, Mourelle M, Langer T, Guccione S, Donzella G, Krovat EM, Poptodorov K, Lasheras B, Ballaz S, Hervías I, Tordera R, Del Río J, Monge A.
    J Med Chem; 2002 Sep 12; 45(19):4128-39. PubMed ID: 12213056
    [Abstract] [Full Text] [Related]

  • 6. Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization.
    Millan MJ, Newman-Tancredi A, Lochon S, Touzard M, Aubry S, Audinot V.
    Pharmacol Biochem Behav; 2002 Apr 12; 71(4):589-98. PubMed ID: 11888550
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
    Pullar IA, Boot JR, Carney SL, Cohen ML, Colvin EM, Conway RG, Hardy CH, Lucaites VL, Nelson DL, Schenck KW, Tomlinson R, Wedley S.
    Eur J Pharmacol; 2001 Nov 30; 432(1):9-17. PubMed ID: 11734182
    [Abstract] [Full Text] [Related]

  • 8. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
    Bühlen M, Fink K, Böing C, Göthert M.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb 30; 353(3):281-9. PubMed ID: 8692282
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous vein.
    Cohen ML, Schenck K.
    J Pharmacol Exp Ther; 1999 Sep 30; 290(3):935-9. PubMed ID: 10454462
    [Abstract] [Full Text] [Related]

  • 11. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN, Greenslade RG, Cooper J.
    Eur J Pharmacol; 2001 Nov 30; 432(1):19-27. PubMed ID: 11734183
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor.
    Moloney GP, Martin GR, Mathews N, Milne A, Hobbs H, Dodsworth S, Sang PY, Knight C, Williams M, Maxwell M, Glen RC.
    J Med Chem; 1999 Jul 15; 42(14):2504-26. PubMed ID: 10411472
    [Abstract] [Full Text] [Related]

  • 13. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ, Curtis MJ.
    Br J Pharmacol; 1997 Nov 15; 122(5):875-84. PubMed ID: 9384503
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and pharmacological evaluation of new (indol-3-yl)alkylamides and alkylamines acting as potential serotonin uptake inhibitors.
    Fouchard F, Menciu C, Duflos M, Le Baut G, Lambrey B, Mourgues M, Perrissoud D.
    Arzneimittelforschung; 1999 Feb 15; 49(2):96-105. PubMed ID: 10083976
    [Abstract] [Full Text] [Related]

  • 15. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
    Cohen ML, Schenck KW, Hemrick-Luecke SH.
    J Pharmacol Exp Ther; 1999 Sep 15; 290(3):1195-201. PubMed ID: 10454495
    [Abstract] [Full Text] [Related]

  • 16. Influence of the endothelium and nitric oxide on the contractile responses evoked by 5-HT1D receptor agonists in the rabbit isolated saphenous vein.
    Valentin JP, Bonnafous R, John GW.
    Br J Pharmacol; 1996 Sep 15; 119(1):35-42. PubMed ID: 8872354
    [Abstract] [Full Text] [Related]

  • 17. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C, Soffin EM, Hill M, Atkinson PJ, Langmead CJ, Wren PB, Faedo S, Gordon LJ, Price GW, Bromidge S, Johnson CN, Hagan JJ, Watson J.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):54-61. PubMed ID: 16571351
    [Abstract] [Full Text] [Related]

  • 18. The role of 5-HT(1B/1D) receptors in the modulation of 5-hydroxytryptamine levels in the frontal cortex of the conscious guinea pig.
    Roberts C, Price GW, Jones BJ.
    Eur J Pharmacol; 1997 May 12; 326(1):23-30. PubMed ID: 9178651
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea-pig brain following concurrent 5-HT1A or 5-HT re-uptake site blockade.
    Roberts C, Boyd DF, Middlemiss DN, Routledge C.
    Neuropharmacology; 1999 Sep 12; 38(9):1409-19. PubMed ID: 10471095
    [Abstract] [Full Text] [Related]

  • 20. 3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors.
    Lovell PJ, Blaney FE, Goodacre CJ, Scott CM, Smith PW, Starr KR, Thewlis KM, Vong AK, Ward SE, Watson JM.
    Bioorg Med Chem Lett; 2007 Feb 15; 17(4):1033-6. PubMed ID: 17129726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.